JP2019520393A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520393A5
JP2019520393A5 JP2019500328A JP2019500328A JP2019520393A5 JP 2019520393 A5 JP2019520393 A5 JP 2019520393A5 JP 2019500328 A JP2019500328 A JP 2019500328A JP 2019500328 A JP2019500328 A JP 2019500328A JP 2019520393 A5 JP2019520393 A5 JP 2019520393A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutical composition
pharmaceutically acceptable
emulsion
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2019500328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520393A (ja
Filing date
Publication date
Priority claimed from GBGB1611920.8A external-priority patent/GB201611920D0/en
Application filed filed Critical
Publication of JP2019520393A publication Critical patent/JP2019520393A/ja
Publication of JP2019520393A5 publication Critical patent/JP2019520393A5/ja
Withdrawn legal-status Critical Current

Links

JP2019500328A 2016-07-08 2017-07-06 医薬組成物 Withdrawn JP2019520393A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1611920.8 2016-07-08
GBGB1611920.8A GB201611920D0 (en) 2016-07-08 2016-07-08 Pharmaceutical compositions
PCT/EP2017/066983 WO2018015175A1 (en) 2016-07-08 2017-07-06 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2019520393A JP2019520393A (ja) 2019-07-18
JP2019520393A5 true JP2019520393A5 (enExample) 2020-08-06

Family

ID=56890842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019500328A Withdrawn JP2019520393A (ja) 2016-07-08 2017-07-06 医薬組成物

Country Status (20)

Country Link
US (1) US20200254046A1 (enExample)
EP (1) EP3481377A1 (enExample)
JP (1) JP2019520393A (enExample)
KR (1) KR20190026816A (enExample)
CN (1) CN109414409A (enExample)
AU (1) AU2017298873B2 (enExample)
BR (1) BR112019000240A2 (enExample)
CA (1) CA3029331A1 (enExample)
CL (1) CL2019000042A1 (enExample)
CO (1) CO2019000083A2 (enExample)
CR (1) CR20190007A (enExample)
DO (1) DOP2019000002A (enExample)
EA (1) EA201990162A1 (enExample)
GB (1) GB201611920D0 (enExample)
IL (1) IL263999A (enExample)
MX (1) MX2019000255A (enExample)
PE (1) PE20190321A1 (enExample)
PH (1) PH12019500024A1 (enExample)
SG (1) SG11201811223YA (enExample)
WO (1) WO2018015175A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022071463A1 (ja) * 2020-10-02 2022-04-07 住友精化株式会社 粘性組成物
JPWO2022071461A1 (enExample) * 2020-10-02 2022-04-07

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378444B2 (en) * 2002-06-17 2008-05-27 Brigham And Women's Hospital, Inc. Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
WO2008145183A1 (en) * 2007-05-30 2008-12-04 Nestec S.A. Oil-in-water emulsion and its use for the delayed release of active elements
GB2465988A (en) * 2008-12-03 2010-06-09 Omegatri As Powder or tablet containing unsaturated fatty acid and water insoluble carbohydrate
CN102421422A (zh) * 2009-03-09 2012-04-18 普罗诺瓦生物医药挪威公司 含有脂肪酸油混合物和表面活性剂的组合物及其方法和用途
CN102512664B (zh) * 2010-12-31 2015-04-01 舒泰神(北京)生物制药股份有限公司 一种神经生长因子组合物
CN107050457A (zh) 2012-01-06 2017-08-18 翁特拉制药公司 游离酸形式的ω‑3多不饱和脂肪酸的富含dpa组合物

Similar Documents

Publication Publication Date Title
JP2018184458A5 (enExample)
JP2013508296A5 (enExample)
JPS6410494B2 (enExample)
WO2012013331A2 (en) Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
DE04801160T1 (de) Pharmazeutische zusammensetzungen mit lercanidipin
JP6103111B1 (ja) 経口医薬組成物及び該組成物からなる粒子状製剤の製造方法
JP5795585B2 (ja) 固体粉末化合物からのフィルムコーティング組成物
WO2014170464A1 (en) Encapsulation of an oil containing unsaturated fatty acids
JP2019500416A (ja) デュタステリド及びプロピレングリコールモノラウレートを含有する医薬組成物及びその調製方法
IL273754B1 (en) Fortified oral taxane preparations and methods
JP2019509344A5 (enExample)
JP2024033011A (ja) 医薬組成物
EP3195860A1 (de) Verfahren zur herstellung eines apixaban-granulates
WO2015019237A1 (en) Pharmaceutical composition of vilazodone
PH12022550430A1 (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
JP6371920B2 (ja) 新規薬学組成物
CN101141952B (zh) 新的软胶囊
JP2019534046A5 (enExample)
WO2018069805A3 (en) Method for preparation of liquid oral composition of l-thyroxin
RU2016136666A (ru) Составы на основе прогестерона
WO2015016698A1 (es) Composición farmacéutica con agentes antiinflamatorios y proceso de producción
JP5191121B2 (ja) 溶解性を改善したジフェンヒドラミン含有医薬組成物
JP2019520393A (ja) 医薬組成物
JP6824816B2 (ja) 口腔内崩壊性被覆錠剤及び口腔内崩壊性被覆錠剤の被覆層用組成物
RU2015132458A (ru) Пленочное покрытие препаративных форм, содержащих биологически активные вещества, суспензия для его формирования и способ его нанесения